Free Trial

EKF Diagnostics (LON:EKF) Trading Down 7% - Should You Sell?

EKF Diagnostics logo with Medical background

Key Points

  • EKF Diagnostics experienced a significant drop in share price, falling by 7% to trade at GBX 26 ($0.35) after closing at GBX 27.95 ($0.37).
  • The company reported a return on equity of 7.03% and earnings per share of GBX 0.43 for the most recent quarter.
  • With a market capitalization of £116.76 million, EKF Diagnostics focuses on diagnostics in Hematology and Diabetes and operates globally, selling products in over 120 countries.
  • MarketBeat previews top five stocks to own in November.

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report)'s share price fell 7% during trading on Saturday . The stock traded as low as GBX 23.60 ($0.31) and last traded at GBX 26 ($0.35). 2,281,890 shares were traded during mid-day trading, an increase of 404% from the average session volume of 453,091 shares. The stock had previously closed at GBX 27.95 ($0.37).

EKF Diagnostics Trading Down 7.0%

The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60. The firm has a market capitalization of £116.76 million, a price-to-earnings ratio of 19.26 and a beta of 0.57. The company has a 50 day moving average price of GBX 29.18 and a two-hundred day moving average price of GBX 26.59.

EKF Diagnostics (LON:EKF - Get Free Report) last announced its earnings results on Tuesday, September 16th. The company reported GBX 0.43 earnings per share for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. On average, research analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

EKF Diagnostics Company Profile

(Get Free Report)

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EKF Diagnostics Right Now?

Before you consider EKF Diagnostics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EKF Diagnostics wasn't on the list.

While EKF Diagnostics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.